• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Severe prolongation of the INR in spur cell anemia of cirrhosis: true-true and related?

作者信息

Sundaram Vinay, Al-Osaimi Abdullah M S, Lewis Jason J, Lisman Ton, Caldwell Stephen H

机构信息

Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Virginia Health System, Charlottesville, Virginia 22908-0708, USA.

出版信息

Dig Dis Sci. 2006 Jul;51(7):1203-5. doi: 10.1007/s10620-006-8033-8.

DOI:10.1007/s10620-006-8033-8
PMID:16944010
Abstract
摘要

相似文献

1
Severe prolongation of the INR in spur cell anemia of cirrhosis: true-true and related?肝硬化伴棘形细胞贫血时国际标准化比值（INR）严重延长：确有其事且有关联？
Dig Dis Sci. 2006 Jul;51(7):1203-5. doi: 10.1007/s10620-006-8033-8.
2
Oxidative stress, NOx/l-arginine ratio and glutathione/glutathione S-transferase ratio as predictors of 'sterile inflammation' in patients with alcoholic cirrhosis and hepatorenal syndrome type II.氧化应激、NOx/精氨酸比值和谷胱甘肽/谷胱甘肽 S-转移酶比值作为预测酒精性肝硬化和肝肾综合征 II 型患者“无菌性炎症”的指标。
Ren Fail. 2018 Nov;40(1):340-349. doi: 10.1080/0886022X.2018.1459699.
3
Spur cell anemia in alcoholic cirrhosis: cure by orthotopic liver transplantation and recurrence after liver graft failure.酒精性肝硬化中的棘形细胞贫血：原位肝移植治愈及肝移植失败后的复发
Int Surg. 2002 Oct-Dec;87(4):201-4.
4
Diagnostical significance of dimethylarginine in the development of hepatorenal syndrome in patients with alcoholic liver cirrhosis.二甲基精氨酸在酒精性肝硬化患者肝肾综合征发生中的诊断意义
Vojnosanit Pregl. 2012 Aug;69(8):686-91.
5
Education and imaging. Hepatobiliary and pancreatic: spur cell anemia associated with alcoholic cirrhosis.教育与影像学。肝胆胰：与酒精性肝硬化相关的棘状细胞贫血。
J Gastroenterol Hepatol. 2008 Sep;23(9):1463. doi: 10.1111/j.1440-1746.2008.05589.x.
6
Predictors of hepatorenal syndrome in alcoholic liver cirrhosis.酒精性肝硬化患者肝肾综合征的预测因素
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Dec;159(4):661-5. doi: 10.5507/bp.2015.010. Epub 2015 Mar 26.
7
Clinical utility of red cell distribution width in alcoholic and non-alcoholic liver cirrhosis.红细胞分布宽度在酒精性和非酒精性肝硬化中的临床应用
Coll Antropol. 2011 Sep;35 Suppl 2:335-8.
8
Spur-cell anemia.
Cleve Clin J Med. 2020 Nov 2;87(11):649-650. doi: 10.3949/ccjm.87a.20044.
9
[A case of alcoholic cirrhosis with spur cell anemia].[一例酒精性肝硬化伴棘形细胞贫血病例]
Nihon Naika Gakkai Zasshi. 1989 Jul;78(7):953-7. doi: 10.2169/naika.78.953.
10
[Hepatorenal syndrome. Cases report].
Pol Arch Med Wewn. 2005 Oct;114(4):982-8.

引用本文的文献

1
Spur Cell Anaemia in Cirrhosis: A Narrative Review.肝硬化中的棘形细胞贫血：一项叙述性综述。
J Clin Exp Hepatol. 2023 May-Jun;13(3):500-508. doi: 10.1016/j.jceh.2022.10.005. Epub 2022 Oct 11.
2
The Diagnosis Is in the Smear: A Case and Review of Spur Cell Anemia in Cirrhosis.诊断见于涂片：肝硬化中棘形细胞贫血的一例病例及综述
Case Rep Hematol. 2021 Mar 26;2021:8883335. doi: 10.1155/2021/8883335. eCollection 2021.
3
Spur cell anemia related to alcoholic liver cirrhosis managed without liver transplantation: a case report and literature review.

本文引用的文献

1
Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation.特定的实验室检测方法能使列入肝移植名单的患者获得更高的终末期肝病模型（MELD）评分。
Liver Transpl. 2004 Aug;10(8):995-1000. doi: 10.1002/lt.20195.
2
Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: a break from convention in need of controlled trials.
Hepatology. 2004 Mar;39(3):592-8. doi: 10.1002/hep.20123.
3
Jaundice, hyperlipemia and hemolytic anemia: a heretofore unrecognized syndrome associated with alcoholic fatty liver and cirrhosis.黄疸、高脂血症和溶血性贫血：一种迄今为止未被认识的与酒精性脂肪肝和肝硬化相关的综合征。
酒精性肝硬化相关棘状红细胞贫血：病例报告并文献复习。
Clin J Gastroenterol. 2020 Oct;13(5):882-890. doi: 10.1007/s12328-020-01142-3. Epub 2020 May 29.
4
Longitudinal assessment of prognostic factors for patients with hepatorenal syndrome in a tertiary center.三级中心肝肾综合征患者预后因素的纵向评估。
Hepatol Int. 2010 May 19;4(2):507-10. doi: 10.1007/s12072-010-9180-8.
Ann Intern Med. 1958 Mar;48(3):471-96. doi: 10.7326/0003-4819-48-3-471.
4
New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa.凝血系统的新见解及重组凝血因子VIIa新治疗选择的意义。
Curr Med Chem. 2003 May;10(10):797-811. doi: 10.2174/0929867033457728.
5
Relationship between platelet membrane lipid compositions and platelet aggregability in alcoholic liver disease.
Alcohol Clin Exp Res. 1998 May;22(S3 Pt 1):97S-102S. doi: 10.1111/acer.1998.22.s3_part1.97s.
6
Resolution of spur cell anemia with liver transplantation: a case report and review of the literature.肝移植治愈棘状细胞贫血：一例报告并文献复习
Transplantation. 1998 Apr 15;65(7):993-5. doi: 10.1097/00007890-199804150-00021.
7
Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio?肝衰竭中的凝血酶原时间：时间、比值、活性百分比还是国际标准化比值？
Hepatology. 1996 Dec;24(6):1392-4. doi: 10.1053/jhep.1996.v24.pm0008938167.
8
Contribution of different phospholipid classes to the prothrombin converting capacity of sonicated lipid vesicles.不同磷脂类别对超声处理脂质囊泡凝血酶原转化能力的贡献。
Thromb Res. 1996 Feb 15;81(4):419-26. doi: 10.1016/0049-3848(96)00014-x.
9
The international normalized ratio. A guide to understanding and correcting its problems.
Arch Intern Med. 1994 Feb 14;154(3):282-8. doi: 10.1001/archinte.154.3.282.
10
Red cell lipid abnormalities in acquired acanthocytosis are extended to platelets.获得性棘红细胞增多症中的红细胞脂质异常也扩展至血小板。
Br J Haematol. 1994 Jul;87(3):614-6. doi: 10.1111/j.1365-2141.1994.tb08322.x.